HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Taha E Taha Selected Research

Infections

1/2021Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study.
1/2018Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE): A Randomized, Open-Label, Clinical Trial.
12/2016Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women.
1/2016Antiretroviral Therapy for the Prevention of HIV-1 Transmission.
4/2014Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial.
1/2013Pooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission.
8/2011Prevention of HIV-1 infection with early antiretroviral therapy.
4/2011Initiation of antiretroviral treatment in women after delivery can induce multiclass drug resistance in breastfeeding HIV-infected infants.
11/2008The role of transplacental microtransfusions of maternal lymphocytes in HIV transmission to newborns.
10/2008Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Taha E Taha Research Topics

Disease

16Infections
01/2021 - 09/2002
8Chorioamnionitis
07/2009 - 11/2005
7HIV Infections (HIV Infection)
10/2021 - 11/2008
5Bacterial Vaginosis
02/2014 - 03/2006
5Premature Birth (Birth, Premature)
07/2009 - 03/2006
4Birth Weight (Birth Weights)
11/2016 - 09/2002
4Acquired Immunodeficiency Syndrome (AIDS)
01/2016 - 11/2007
2Trichomonas Infections
03/2006 - 07/2005
1COVID-19
01/2022
1Respiratory Tract Infections (Respiratory Tract Infection)
09/2021
1Infant Death
11/2016
1Tuberculosis (Tuberculoses)
04/2014
1Sepsis (Septicemia)
12/2009
1Neutropenia
10/2008
1Perinatal Death
06/2008
1Sexually Transmitted Diseases (Sexually Transmitted Disease)
07/2005
1Gonorrhea
07/2005
1Acute-Phase Reaction
02/2005
1Inflammation (Inflammations)
02/2005
1Pulmonary Tuberculosis
12/2004
1Malnutrition (Nutritional Deficiencies)
12/2004
1Coinfection
12/2004
1Anemia
09/2002

Drug/Important Bio-Agent (IBA)

10Anti-Bacterial Agents (Antibiotics)IBA
12/2009 - 11/2005
6Nevirapine (Viramune)FDA Link
10/2021 - 11/2007
4Zidovudine (Retrovir)FDA LinkGeneric
11/2016 - 11/2007
3Contraceptive Agents (Contraceptives)IBA
01/2018 - 05/2008
3Vitamin A (Retinol)FDA LinkGeneric
02/2005 - 09/2002
2DapivirineIBA
01/2021 - 12/2016
2Coloring Agents (Dyes)IBA
02/2014 - 07/2005
2DNA (Deoxyribonucleic Acid)IBA
07/2011 - 11/2008
2Pharmaceutical PreparationsIBA
10/2008 - 06/2006
2Anti-Infective Agents (Microbicides)IBA
02/2007 - 07/2005
1Carbapenems (Carbapenem Antibiotics)IBA
09/2021
1Tenofovir (Viread)FDA Link
11/2016
1EnzymesIBA
07/2011
1DNA-Directed DNA Polymerase (Polymerases, DNA)IBA
10/2008
1Biological ProductsIBA
06/2008
1Hemoglobins (Hemoglobin)IBA
06/2008
1Iron-Dextran Complex (InFed)FDA Link
11/2007
1Metronidazole (Metric)FDA LinkGeneric
02/2007
1GelsIBA
02/2007
1Fibronectins (Fibronectin)IBA
02/2007
1ORALIT (ORS)IBA
04/2006
1Nucleic AcidsIBA
07/2005
1C-Reactive ProteinIBA
02/2005
1Orosomucoid (Seromucoid)IBA
02/2005
1MicronutrientsIBA
12/2004
1Carotenoids (Carotene)IBA
12/2004
1ZincIBA
12/2004
1SeleniumIBA
12/2004
1alpha-TocopherolFDA Link
12/2004
1Hepatitis B Surface Antigens (HBsAg)FDA Link
09/2002
1SugarsIBA
09/2002

Therapy/Procedure

3Therapeutics
01/2022 - 08/2011
3Highly Active Antiretroviral Therapy (HAART)
03/2016 - 11/2009
2Art Therapy
10/2021 - 01/2016
2Female Contraceptive Devices (Vaginal Ring)
01/2021 - 12/2016
2Injections
06/2008 - 05/2008
1Treatment Delay
04/2014
1Aftercare (After-Treatment)
02/2007